0000730464false0000730464exch:XNYS2024-10-292024-10-290000730464exch:XCHI2024-10-292024-10-2900007304642024-10-292024-10-29

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): October 29, 2024

ADTALEM GLOBAL EDUCATION INC.

(Exact name of registrant as specified in its charter)

 

Delaware

001-13988

36-3150143

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

 

 

 

500 West Monroe

Chicago, IL

 

60661

(Address of principal executive offices)

 

(Zip Code)

(312) (651-1400)

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol

    

Name of each exchange on
which registered

Common Stock $0.01 Par Value

ATGE

New York Stock Exchange

Common Stock $0.01 Par Value

ATGE

Chicago Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 2.02. Results of Operations and Financial Condition.

On October 29, 2024, Adtalem Global Education Inc. (“Adtalem”) issued a press release announcing its first quarter fiscal 2025 academic, operating and financial results. The press release is attached hereto as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.

The information furnished pursuant to this Item 2.02, including Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of Adtalem under the Securities Act of 1933, as amended, or the Exchange Act.

Cautionary Disclosure Regarding Forward-Looking Statements

Certain statements contained in this Form 8-K and related press release are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact, which includes statements regarding Adtalem’s future growth. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “future,” “believe,” “expect,” “anticipate,” “estimate,” “plan,” “intend,” “may,” “will,” “would,” “could,” “can,” “continue,” “preliminary,” “range,” and similar terms. These forward-looking statements are subject to risk and uncertainties that could cause actual results to differ materially from those described in the statements. These risks and uncertainties include the risk factors described in Item 1A. “Risk Factors” of our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) and our other filings with the SEC. These forward-looking statements are based on information available to us as of the date any such statements are made, and Adtalem assumes no obligation to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied therein will not be realized, except as required by law.

Item 9.01. Financial Statements and Exhibits.

99.1

    

Press Release of Adtalem Global Education Inc., dated October 29, 2024.

104

Cover Page Interactive Data File (formatted in Inline XBRL and included as Exhibit 101)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

ADTALEM GLOBAL EDUCATION INC.

By:

/s/ Robert J. Phelan

Robert J. Phelan

Senior Vice President and Chief Financial Officer

(Principal Financial Officer)

Date: October 29, 2024

Exhibit 99.1

News Release

Graphic

Investor Contact

Jay Spitzer

Investor.Relations@Adtalem.com

+1 312-906-6600

Media Contact

Britt Mitchell

AdtalemMedia@Adtalem.com

+1 872-270-0301

Adtalem Global Education First Quarter Fiscal Year 2025 Results; Guidance Raised

Total enrollment up 11.2% YoY

Revenue up 13.2% YoY

Diluted earnings per share $1.18; Adjusted EPS $1.29, growth of 38.7% YoY

First quarter highlights

Total student enrollment 90,140, up 11.2% year-over-year
Revenue $417.4 million, up 13.2% year-over-year
Chamberlain University seventh straight quarter of total enrollment growth, up 11.7% year-over-year, highest total enrollment in university history
Walden University fifth straight quarter of total enrollment growth, up 12.2% year-over-year
Medical and Veterinary segment fourth straight enrollment period of sequentially improved year-over-year total enrollment trends
Strong momentum starting second year of three-year Growth with Purpose strategy, GAAP net income $46.2 million and adjusted EBITDA $96.7 million, up 20.1% year-over-year

Capital allocation

Repurchased $34 million of shares, $178 million remaining under $300 million Board authorized share repurchase program through January 2027
Repriced $253 million Term Loan B on Aug. 21, 2024, reducing interest rate by 75 bps
Net leverage 1.0x as of Sept. 30, 2024

Fiscal year 2025 guidance

Revenue $1,690 million to $1,730 million
Adjusted earnings per share $5.75 to $5.95

CHICAGO – Oct. 29, 2024 – Adtalem Global Education Inc. (NYSE: ATGE), the leading healthcare educator in the United States, today reported first quarter fiscal year 2025 results (ended Sept. 30, 2024) delivering accelerated total enrollment growth and operational excellence, fueling the Company’s expanded societal reach.

“We entered year two of our three-year Growth with Purpose strategy with strong momentum, further integrating our tech-enabled platform and expanding our impact through innovative partnerships,” said Steve Beard, president and chief executive officer, Adtalem Global Education. “Our reimagined education model creates a more versatile learning experience that adapts to students' needs, driving 11.2% growth in total enrollment. These results give us the confidence to raise our expectations for fiscal year 2025.”

Financial Highlights

Selected financial data for the three months ended Sept. 30, 2024:

Revenue of $417.4 million increased 13.2% compared with the prior year.
Operating income of $70.2 million, compared with $28.2 million in the prior year;     adjusted operating income of $75.8 million, compared with $63.3 million in the prior year.
Net income of $46.2 million, compared with $10.6 million in the prior year;                   adjusted net income of $50.5 million, compared with $39.4 million in the prior year.
Diluted earnings per share of $1.18, compared with $0.25 in the prior year;                adjusted earnings per share of $1.29, compared with $0.93 in the prior year.
Adjusted EBITDA of $96.7 million, compared with $80.5 million in the prior year;         adjusted EBITDA margin of 23.2%, compared with 21.8% in the prior year.

Business Highlights

Chamberlain University expanded its specialized nursing education Practice Ready. Specialty Focused.™ (PRSF) model through a partnership with the Oncology Nursing Society (ONS), offering an introduction to caring for cancer patients and their families. The ONS offering joins other specializations in the PRSF model, including critical care, emergency nursing, nephrology, home healthcare and perioperative nursing.
Adtalem announced a partnership with Hippocratic AI to develop a new curriculum focused on training healthcare professionals in the use of AI technologies. The initiative includes the first-ever AI certification, designed for both Chamberlain University and Walden University students, as well as practicing clinicians, focused on essential skills to effectively evaluate, navigate and ethically utilize AI tools in patient care.
Ross University School of Veterinary Medicine ranked third for most graduates placed into the highly sought after Veterinary Internship and Residency Matching Program™ (VIRMP) for 2024. Our students matched into specialties including anesthesia, large animal surgery, medical oncology, veterinary dermatology and radiology.

Chamberlain University's Bachelor of Science in Nursing and Master of Science in Nursing degree programs received continuing accreditation by the Commission on Collegiate Nursing Education (CCNE) for the maximum accreditation period of 10 years. Chamberlain's Doctor of Nursing Practice degree program also recently received continuing accreditation by the National League for Nursing Commission for Nursing Education Accreditation (NLN CNEA) for the accreditation period of 10 years.
Adtalem recently released its 2024 Sustainability Report, which highlights the Company’s collective efforts to address critical workforce shortages in the U.S. healthcare system by strengthening pathways to high-quality education and promoting health equity.

Segment Highlights

Chamberlain

$ in millions

Three Months Ended

September 30,

2024

2023

% Change

Revenue

$167.9

$142.6

17.8%

Operating Income

$26.0

$24.3

6.8%

Adj. Operating Income

$27.8

$24.3

14.4%

Adj. EBITDA

$37.0

$31.5

17.2%

Total Students (1)

38,987

34,889

11.7%

Total student enrollment increased 11.7% compared with the prior year, driven by continued growth in pre-licensure and post-licensure nursing programs.

Walden

$ in millions

Three Months Ended

September 30,

2024

2023

% Change

Revenue

$161.5

$141.6

14.1%

Operating Income

$39.8

$1.9

1,955.6%

Adj. Operating Income

$42.6

$31.1

37.0%

Adj. EBITDA

$47.8

$35.1

35.9%

Total Students (1)

45,979

40,975

12.2%

Total student enrollment increased 12.2% compared with the prior year, driven by growth in healthcare and non-healthcare programs.

Medical and Veterinary

$ in millions

Three Months Ended

September 30,

2024

2023

% Change

Revenue

$88.0

$84.6

3.9%

Operating Income

$14.7

$14.4

2.1%

Adj. Operating Income

$14.7

$14.5

1.7%

Adj. EBITDA

$19.2

$19.1

0.7%

Total Students (1)

5,174

5,209

(0.7)%

Total student enrollment decreased 0.7% compared with the prior year, driven by declines at medical.


Fiscal Year 2025 Outlook

Adtalem raises guidance for fiscal year 2025, with revenue in the range of $1,690 million to $1,730 million, approximately 6.5% to 9.0% growth year-over-year. Adjusted earnings per share to be in the range of $5.75 to $5.95, approximately 14.5% to 18.5% growth year-over-year.

Conference Call and Webcast Information

Adtalem will hold a conference call to discuss its first quarter fiscal year 2025 results today at 4:00 p.m. CT (5:00 p.m. ET).

The call can be accessed by dialing +1 877-407-6184 (U.S. participants) or +1 201-389-0877 (international participants) and stating “Adtalem earnings call” or by using conference ID: 13749198. The call will be simulcast through the Adtalem investor relations website at: https://investors.adtalem.com.

Adtalem will archive a replay of the call for 30 days. To access the replay, dial +1 877-660-6853 (U.S.) or +1 201-612-7415 (international), conference ID: 13749198, or visit the Adtalem investor relations website.

About Adtalem Global Education

Adtalem Global Education is the leading provider of healthcare education in the U.S., shaping the future of healthcare by preparing a diverse workforce with high-quality academic programs. We innovate education pathways, align with industry needs and empower individuals to reach their full potential. Our commitment to excellence and inclusivity is reflected in our expansive network of institutions, serving over 90,000 students and supported by a strong community of approximately 350,000 alumni and nearly 10,000 dedicated employees. Visit Adtalem.com for more information and follow us on LinkedIn, Instagram and Facebook.

Cautionary Disclosure Regarding Forward-Looking Statements

Certain statements contained in this release are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact, which includes statements regarding Adtalem’s future growth. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “future,” “believe,” “expect,” “anticipate,” “estimate,” “plan,” “intend,” “may,” “will,” “would,” “could,” “can,” “continue,” “preliminary,” “range,” and similar terms. These forward-looking statements are subject to risk and uncertainties that could cause actual results to differ materially from those described in the statements. These risks and uncertainties include the risk factors described in Item 1A. “Risk Factors” of our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (SEC) and our other filings with the SEC. These forward-looking statements are based on information available to us as of the date any such statements are made, and Adtalem assumes no obligation to publicly update or revise its forward-looking statements even if experience or future changes make it clear that any projected results expressed or implied therein will not be realized, except as required by law.


A reconciliation of non-GAAP guidance measures to corresponding GAAP measures is not available on a forward-looking basis without unreasonable effort due to the uncertainty of special items that may be incurred in the future, although these special items could be material to Adtalem's results in accordance with GAAP.

1 Represents total students attending sessions during each institution’s most recent enrollment period in Q1 FY 2025 and Q1 FY 2024.

###


Adtalem Global Education Inc.

Consolidated Balance Sheets

(unaudited)

(in thousands)

September 30,

June 30,

    

2024

2024

Assets:

Current assets:

Cash and cash equivalents

$

264,798

$

219,306

Restricted cash

 

2,074

 

1,896

Accounts and financing receivables, net

 

171,509

 

126,833

Prepaid expenses and other current assets

 

78,533

 

70,050

Total current assets

 

516,914

 

418,085

Noncurrent assets:

 

  

 

  

Property and equipment, net

 

244,503

 

248,524

Operating lease assets

 

171,921

 

176,755

Deferred income taxes

 

33,454

 

49,088

Intangible assets, net

 

773,889

 

776,694

Goodwill

 

961,262

 

961,262

Other assets, net

 

107,939

 

103,184

Assets held for sale

 

7,825

 

7,825

Total noncurrent assets

 

2,300,793

 

2,323,332

Total assets

$

2,817,707

$

2,741,417

Liabilities and shareholders' equity:

 

  

 

  

Current liabilities:

 

  

 

  

Accounts payable

$

91,421

$

102,626

Accrued payroll and benefits

 

49,839

 

71,373

Accrued liabilities

 

87,212

 

96,957

Deferred revenue

 

290,571

 

185,272

Current operating lease liabilities

 

32,266

 

31,429

Total current liabilities

 

551,309

 

487,657

Noncurrent liabilities:

 

 

Long-term debt

 

649,318

 

648,712

Long-term operating lease liabilities

 

161,757

 

167,712

Deferred income taxes

 

30,348

 

29,526

Other liabilities

 

35,023

 

38,675

Total noncurrent liabilities

 

876,446

 

884,625

Total liabilities

 

1,427,755

 

1,372,282

Commitments and contingencies

 

 

Total shareholders' equity

 

1,389,952

 

1,369,135

Total liabilities and shareholders' equity

$

2,817,707

$

2,741,417


Adtalem Global Education Inc.

Consolidated Statements of Income

(unaudited)

(in thousands, except per share data)

Three Months Ended

September 30,

2024

2023

Revenue

$

417,400

$

368,845

Operating cost and expense:

 

Cost of educational services

 

185,995

 

168,618

Student services and administrative expense

 

159,073

 

166,095

Restructuring expense

 

2,094

 

676

Business integration expense

 

 

5,262

Total operating cost and expense

 

347,162

 

340,651

Operating income

 

70,238

 

28,194

Interest expense

 

(14,482)

 

(15,657)

Other income, net

 

2,646

 

2,214

Income from continuing operations before income taxes

 

58,402

 

14,751

Provision for income taxes

 

(12,157)

 

(2,792)

Income from continuing operations

 

46,245

 

11,959

Discontinued operations:

 

Loss from discontinued operations before income taxes

 

(107)

 

(1,765)

Benefit from income taxes

 

27

 

452

Loss from discontinued operations

 

(80)

 

(1,313)

Net income and comprehensive income

$

46,165

$

10,646

Earnings (loss) per share:

 

Basic:

 

Continuing operations

$

1.23

$

0.29

Discontinued operations

$

(0.00)

$

(0.03)

Total basic earnings per share

$

1.22

$

0.26

Diluted:

 

 

Continuing operations

$

1.18

$

0.28

Discontinued operations

$

(0.00)

$

(0.03)

Total diluted earnings per share

$

1.18

$

0.25

Weighted-average shares outstanding:

Basic shares

37,721

41,399

Diluted shares

39,109

42,184


Adtalem Global Education Inc.

Consolidated Statements of Cash Flows
(unaudited)

(in thousands)

Three Months Ended

September 30,

2024

2023

Operating activities:

Net income

$

46,165

$

10,646

Loss from discontinued operations

 

80

 

1,313

Income from continuing operations

46,245

11,959

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

Stock-based compensation

 

9,451

 

7,455

Amortization and impairments to operating lease assets

6,948

8,765

Depreciation

 

9,803

 

9,338

Amortization of acquired intangible assets

 

2,805

 

10,677

Amortization of debt discount and issuance costs

1,113

1,155

Provision for bad debts

13,720

10,226

Deferred income taxes

 

16,456

 

2,165

Loss on disposals of property and equipment

 

107

 

38

(Gain) loss on investments

(613)

447

Changes in assets and liabilities:

 

 

Accounts and financing receivables

 

(56,803)

 

(54,867)

Prepaid expenses and other current assets

 

(7,389)

 

(5,532)

Cloud computing implementation assets

 

(7,888)

 

(4,224)

Accounts payable

 

(8,508)

 

(2,818)

Accrued payroll and benefits

(21,501)

(8,882)

Accrued liabilities

 

(8,467)

 

13,770

Deferred revenue

 

106,156

 

98,658

Operating lease liabilities

(7,232)

(10,053)

Other assets and liabilities

 

(4,836)

 

(2,163)

Net cash provided by operating activities-continuing operations

 

89,567

 

86,114

Net cash (used in) provided by operating activities-discontinued operations

 

(251)

 

8,959

Net cash provided by operating activities

 

89,316

 

95,073

Investing activities:

 

Capital expenditures

 

(10,414)

 

(10,434)

Proceeds from sales of marketable securities

 

2,187

 

400

Purchases of marketable securities

 

(1,308)

 

(300)

Net cash used in investing activities

 

(9,535)

 

(10,334)

Financing activities:

 

Proceeds from exercise of stock options

 

9,498

 

550

Employee taxes paid on withholding shares

 

(10,717)

 

(5,651)

Proceeds from stock issued under Colleague Stock Purchase Plan

 

298

 

190

Repurchases of common stock for treasury

 

(33,190)

 

(90,477)

Proceeds from issuance of long-term debt

 

9,873

 

Repayments of long-term debt

 

(9,873)

 

Net cash used in financing activities

 

(34,111)

 

(95,388)

Net increase (decrease) in cash, cash equivalents and restricted cash

 

45,670

 

(10,649)

Cash, cash equivalents and restricted cash at beginning of period

 

221,202

 

275,075

Cash, cash equivalents and restricted cash at end of period

$

266,872

$

264,426

Non-cash investing and financing activities:

Accrued capital expenditures

$

4,193

$

6,087

Accrued liability for repurchases of common stock

$

800

$

3,600

Accrued excise tax on share repurchases

$

3,259

$

1,928


Adtalem Global Education Inc.

Segment Information

(unaudited)

(in thousands)

Three Months Ended

September 30,

Increase/(Decrease)

    

2024

2023

    

$

%

Revenue:

Chamberlain

$

167,930

$

142,596

$

25,334

17.8

%

Walden

161,513

141,608

19,905

14.1

%

Medical and Veterinary

87,957

84,641

3,316

3.9

%

Total consolidated revenue

$

417,400

$

368,845

$

48,555

13.2

%

Operating income (loss):

Chamberlain

$

25,974

$

24,324

$

1,650

6.8

%

Walden

39,837

1,938

37,899

1,955.6

%

Medical and Veterinary

14,671

14,363

308

2.1

%

Home Office

(10,244)

(12,431)

2,187

17.6

%

Total consolidated operating income

$

70,238

$

28,194

$

42,044

149.1

%

Non-GAAP Financial Measures and Reconciliations

We believe that certain non-GAAP financial measures provide investors with useful supplemental information regarding the underlying business trends and performance of Adtalem’s ongoing operations as seen through the eyes of management and are useful for period-over-period comparisons. We use these supplemental non-GAAP financial measures internally in our assessment of performance and budgeting process. However, these non-GAAP financial measures should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. The following are non-GAAP financial measures used in the subsequent GAAP to non-GAAP reconciliation tables:

Adjusted net income (most comparable GAAP measure: net income) – Measure of Adtalem’s net income adjusted for restructuring expense, business integration expense, amortization of acquired intangible assets, litigation reserve, debt modification costs, and loss from discontinued operations.

Adjusted earnings per share (most comparable GAAP measure: diluted earnings per share) – Measure of Adtalem’s diluted earnings per share adjusted for restructuring expense, business integration expense, amortization of acquired intangible assets, litigation reserve, debt modification costs, and loss from discontinued operations.

Adjusted operating income (most comparable GAAP measure: operating income) – Measure of Adtalem’s operating income adjusted for restructuring expense, business integration expense, amortization of acquired intangible assets, litigation reserve, and debt modification costs. This measure is applied on a consolidated and segment basis, depending on the context of the discussion.

Adjusted EBITDA (most comparable GAAP measure: net income) – Measure of Adtalem’s net income adjusted for loss from discontinued operations, interest expense, other income, net, provision for income taxes, depreciation, amortization of acquired intangible assets, amortization of cloud computing implementation assets, stock-based compensation, restructuring expense, business integration expense, litigation reserve, and debt modification costs. This measure is applied on a consolidated and segment basis, depending on the context of the discussion. Provision for income taxes, interest expense, and other income, net is not recorded at the reportable segments, and therefore, the segment adjusted EBITDA reconciliations begin with operating income.

Free cash flow (most comparable GAAP measure: net cash provided by operating activities-continuing operations) – Defined as net cash provided by operating activities-continuing operations less capital expenditures.


Net debt – Defined as long-term debt less cash and cash equivalents.

Net leverage – Defined as net debt divided by adjusted EBITDA.

A description of special items in our non-GAAP financial measures described above are as follows:

Restructuring expense primarily related to workforce reductions, costs to exit certain course offerings, and prior real estate consolidations at Adtalem’s home office. We do not include normal, recurring, cash operating expenses in our restructuring expense.
Business integration expense include expenses related to the Walden acquisition and certain costs related to growth transformation initiatives. We do not include normal, recurring, cash operating expenses in our business integration expense.
Amortization of acquired intangible assets.
Amortization of cloud computing implementation assets.
Reserves related to significant litigation and debt modification costs related to refinancing our Term Loan B loan.
Loss from discontinued operations includes expense from ongoing litigation costs and settlements related to the DeVry University and Carrington College divestitures.


Adtalem Global Education Inc.

Non-GAAP Operating Income by Segment

(unaudited)

(in thousands)

Three Months Ended

September 30,

Increase/(Decrease)

2024

2023

$

%

Chamberlain:

Operating income (GAAP)

$

25,974

$

24,324

$

1,650

6.8

%

Restructuring expense

1,858

1,858

Adjusted operating income (non-GAAP)

$

27,832

$

24,324

$

3,508

14.4

%

Operating margin (GAAP)

15.5

%

17.1

%

Operating margin (non-GAAP)

16.6

%

17.1

%

Walden:

Operating income (GAAP)

$

39,837

$

1,938

$

37,899

1,955.6

%

Amortization of acquired intangible assets

2,805

10,677

(7,872)

Litigation reserve

18,500

(18,500)

Adjusted operating income (non-GAAP)

$

42,642

$

31,115

$

11,527

37.0

%

Operating margin (GAAP)

24.7

%

1.4

%

Operating margin (non-GAAP)

26.4

%

22.0

%

Medical and Veterinary:

Operating income (GAAP)

$

14,671

$

14,363

$

308

2.1

%

Restructuring expense

59

114

(55)

Adjusted operating income (non-GAAP)

$

14,730

$

14,477

$

253

1.7

%

Operating margin (GAAP)

16.7

%

17.0

%

Operating margin (non-GAAP)

16.7

%

17.1

%

Home Office:

Operating loss (GAAP)

$

(10,244)

$

(12,431)

$

2,187

17.6

%

Restructuring expense

177

562

(385)

Business integration expense

5,262

(5,262)

Debt modification costs

712

712

Adjusted operating loss (non-GAAP)

$

(9,355)

$

(6,607)

$

(2,748)

(41.6)

%

Adtalem Global Education:

Operating income (GAAP)

$

70,238

$

28,194

$

42,044

149.1

%

Restructuring expense

2,094

676

1,418

Business integration expense

5,262

(5,262)

Amortization of acquired intangible assets

2,805

10,677

(7,872)

Litigation reserve

18,500

(18,500)

Debt modification costs

712

712

Adjusted operating income (non-GAAP)

$

75,849

$

63,309

$

12,540

19.8

%

Operating margin (GAAP)

16.8

%

7.6

%

Operating margin (non-GAAP)

18.2

%

17.2

%


Adtalem Global Education Inc.

Non-GAAP Adjusted EBITDA by Segment

(unaudited)

(in thousands)

Three Months Ended

September 30,

Increase/(Decrease)

2024

2023

$

%

Chamberlain:

Operating income (GAAP)

$

25,974

$

24,324

$

1,650

6.8

%

Restructuring expense

1,858

1,858

Depreciation

5,368

4,116

1,252

Amortization of cloud computing implementation assets

652

200

452

Stock-based compensation

3,119

2,907

212

Adjusted EBITDA (non-GAAP)

$

36,971

$

31,547

$

5,424

17.2

%

Adjusted EBITDA margin (non-GAAP)

22.0

%

22.1

%

Walden:

Operating income (GAAP)

$

39,837

$

1,938

$

37,899

1,955.6

%

Amortization of acquired intangible assets

2,805

10,677

(7,872)

Litigation reserve

18,500

(18,500)

Depreciation

1,682

1,974

(292)

Amortization of cloud computing implementation assets

701

188

513

Stock-based compensation

2,740

1,864

876

Adjusted EBITDA (non-GAAP)

$

47,765

$

35,141

$

12,624

35.9

%

Adjusted EBITDA margin (non-GAAP)

29.6

%

24.8

%

Medical and Veterinary:

Operating income (GAAP)

$

14,671

$

14,363

$

308

2.1

%

Restructuring expense

59

114

(55)

Depreciation

2,569

2,892

(323)

Amortization of cloud computing implementation assets

283

52

231

Stock-based compensation

1,607

1,640

(33)

Adjusted EBITDA (non-GAAP)

$

19,189

$

19,061

$

128

0.7

%

Adjusted EBITDA margin (non-GAAP)

21.8

%

22.5

%

Home Office:

Operating loss (GAAP)

$

(10,244)

$

(12,431)

$

2,187

17.6

%

Restructuring expense

177

562

(385)

Business integration expense

5,262

(5,262)

Debt modification costs

712

712

Depreciation

184

356

(172)

Stock-based compensation

1,985

1,044

941

Adjusted EBITDA (non-GAAP)

$

(7,186)

$

(5,207)

$

(1,979)

(38.0)

%

Adtalem Global Education:

Net income (GAAP)

$

46,165

$

10,646

$

35,519

333.6

%

Loss from discontinued operations

80

1,313

(1,233)

Interest expense

14,482

15,657

(1,175)

Other income, net

(2,646)

(2,214)

(432)

Provision for income taxes

12,157

2,792

9,365

Operating income (GAAP)

70,238

28,194

42,044

Depreciation and amortization

14,244

20,455

(6,211)

Stock-based compensation

9,451

7,455

1,996

Restructuring expense

2,094

676

1,418

Business integration expense

5,262

(5,262)

Litigation reserve

18,500

(18,500)

Debt modification costs

712

712

Adjusted EBITDA (non-GAAP)

$

96,739

$

80,542

$

16,197

20.1

%

Adjusted EBITDA margin (non-GAAP)

23.2

%

21.8

%


Adtalem Global Education Inc.

Non-GAAP Earnings Disclosure

(unaudited)

(in thousands, except per share data)

Three Months Ended

September 30,

2024

2023

Net income (GAAP)

$

46,165

$

10,646

Restructuring expense

2,094

676

Business integration expense

5,262

Amortization of acquired intangible assets

2,805

10,677

Litigation reserve and debt modification costs

712

18,500

Income tax impact on non-GAAP adjustments (1)

(1,332)

(7,693)

Loss from discontinued operations

80

1,313

Adjusted net income (non-GAAP)

$

50,524

$

39,381

(1)Represents the income tax impact of non-GAAP continuing operations adjustments that is recognized in our GAAP financial statements.

Three Months Ended

September 30,

2024

2023

Diluted earnings per share (GAAP)

$

1.18

$

0.25

Effect on diluted earnings per share:

Restructuring expense

0.05

0.02

Business integration expense

-

0.12

Amortization of acquired intangible assets

0.07

0.25

Litigation reserve and debt modification costs

0.02

0.44

Income tax impact on non-GAAP adjustments (1)

(0.03)

(0.18)

Loss from discontinued operations

0.00

0.03

Adjusted earnings per share (non-GAAP)

$

1.29

$

0.93

Diluted shares used in non-GAAP EPS calculation

39,109

42,184

Note: May not sum due to rounding.

(1)Represents the income tax impact of non-GAAP continuing operations adjustments that is recognized in our GAAP financial statements.


Adtalem Global Education Inc.

Non-GAAP Free Cash Flow Disclosure

(unaudited)

(in thousands)

Three Months Ended

Twelve Months Ended

FY24

FY25

FY24

FY24

FY24

FY24

FY25

    

Q1

Q1

    

Q1

Q2

Q3

Q4

Q1

Net cash provided by operating activities-continuing operations (GAAP)

$

86,114

$

89,567

$

189,501

$

227,600

$

276,843

$

288,367

$

291,820

Capital expenditures

(10,434)

(10,414)

(31,070)

(38,713)

(44,137)

(48,893)

(48,873)

Free cash flow (non-GAAP)

$

75,680

$

79,153

$

158,431

$

188,887

$

232,706

$

239,474

$

242,947

Adtalem Global Education Inc.

Non-GAAP Net Leverage Disclosure

(unaudited)

(in thousands)

Twelve Months Ended

September 30, 2024

Adtalem Global Education:

Net income (GAAP)

$

172,296

Income from discontinued operations

(297)

Interest expense

62,484

Other income, net

(10,974)

Provision for income taxes

35,589

Depreciation and amortization

72,241

Stock-based compensation

27,943

Restructuring expense

3,288

Business integration expense

28,953

Loss on assets held for sale

647

Debt modification costs

1,560

Adjusted EBITDA (non-GAAP)

$

393,730

September 30, 2024

Long-term debt

$

658,283

Less: Cash and cash equivalents

(264,798)

Net debt (non-GAAP)

$

393,485

Net leverage (non-GAAP)

1.0 x


v3.24.3
Document and Entity Information
Oct. 29, 2024
Document Information [Line Items]  
Document Type 8-K
Document Period End Date Oct. 29, 2024
Entity File Number 001-13988
Entity Registrant Name ADTALEM GLOBAL EDUCATION INC.
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 36-3150143
Entity Address, Address Line One 500 West Monroe
Entity Address, City or Town Chicago
Entity Address, State or Province IL
Entity Address, Postal Zip Code 60661
City Area Code 312
Local Phone Number 651-1400
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0000730464
Amendment Flag false
New York Stock Exchange  
Document Information [Line Items]  
Title of 12(b) Security Common Stock $0.01 Par Value
Trading Symbol ATGE
Security Exchange Name NYSE
Chicago Stock Exchange  
Document Information [Line Items]  
Title of 12(b) Security Common Stock $0.01 Par Value
Trading Symbol ATGE
Security Exchange Name CHX

Adtalem Global Education (NYSE:ATGE)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024 Click aqui para mais gráficos Adtalem Global Education.
Adtalem Global Education (NYSE:ATGE)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024 Click aqui para mais gráficos Adtalem Global Education.